ArticleThe Journal of biological chemistry2013

Comparison of the inhibition mechanisms of adalimumab and infliximab in treating tumor necrosis factor α-associated diseases from a molecular view.

Shi Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.